Neural Therapeutics Inc.
NURL
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.50K | 125.30K | -690.70K | -81.50K | -73.70K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.50K | -115.90K | 482.20K | -5.30K | 5.80K |
| Change in Net Operating Assets | 16.60K | -32.90K | 15.30K | 81.50K | 67.20K |
| Cash from Operations | -36.40K | -23.50K | -193.20K | -5.20K | -700.00 |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -300.00 | 300.00 | -- |
| Total Debt Repaid | -- | -500.00 | -12.40K | -- | -- |
| Issuance of Common Stock | -- | -- | 57.10K | 461.40K | -- |
| Repurchase of Common Stock | -- | -53.20K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -38.50K | -- | -- |
| Cash from Financing | -- | -39.10K | 4.10K | 324.90K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.40K | -62.60K | -189.00K | 319.70K | -700.00 |